Entrada Therapeutics, Inc. is a startup based in the United States, 1 tracked investor.
Entrada Therapeutics, Inc. is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Entrada Therapeutics develops intracellular therapeutics using its proprietary Endosomal Escape Vehicle (EEV) platform to deliver a variety of therapeutic molecules, including RNA, antibodies, and enzymes, aiming to treat serious diseases such as Duchenne Muscular Dystrophy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.